Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoC-2 Virus Infection (COVID-19). A Pilot, Randomized, Simple Blind, Placebo-controlled, Parallel-group Study
收藏DataCite Commons2025-01-06 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00007468/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Evaluation of the efficacy and safety of NTX in adult patients (≥18 years and <60 years),
with SARS-CoV-2 infection with mild symptoms of COVID-19, compared to a placebo control arm.
135 patients will be randomized to either Nitazoxanide (n=90) or placebo (n=45) (2:1). Simple
blind design. Primary endpoint: eradication of virus from patients' respiratory tract
secretions by the 7th day of treatment.
提供机构：
Vivli
创建时间：
2021-10-22
